20933-56-6

Basic information

• Product Name: N-decylglycine
• CAS NO: 20933-56-6
• Molecular Formula: C₁₂H₂₅NO₂
• Molecular Weight: 215.3324
• Mol File: 20933-56-6.mol

Chemical Properties

• Boiling Point: 325.3°C at 760 mmHg
• Flash Point: 150.5°C
• Density: 0.935g/cm³
• Vapor Pressure: 4.69E-05mmHg at 25°C
• Refractive Index: 1.458
• CAS DataBase Reference: N-decylglycine(CAS DataBase Reference)
• NIST Chemistry Reference: N-decylglycine(20933-56-6)
• EPA Substance Registry System: N-decylglycine(20933-56-6)

Safety Data

• Hazardous Substances Data: 20933-56-6(Hazardous Substances Data)

Usage

Uses

Used in Personal Care Industry:
N-decylglycine is used as an emulsifying and foaming agent for its ability to improve the dispersion of ingredients and enhance the stability and lathering properties of products such as shampoos, body washes, and facial cleansers.
Used in Industrial Applications:
In the industrial sector, N-decylglycine serves as a lubricant and corrosion inhibitor, leveraging its surfactant properties to reduce friction and protect against corrosion in various mechanical systems.
However, it is important to note that N-decylglycine, like many surfactants, may pose potential environmental and health risks. Therefore, its use should be carefully regulated and monitored to mitigate any adverse effects.

Upstream product

• 2016-57-1 1-aminodecane 
• 79-11-8 chloroacetic acid 
• 73243-24-0 N-Decyl-glycin-benzylester 
• 112-30-1 1-Decanol 
• 56-40-6 glycine 

Relevant articles and documents

N-ALKYLATED AMINO ACIDS AND OLIGOPEPTIDES, USES THEREOF AND METHODS FOR PROVIDING THEM.

The invention relates to the synthesis of amphiphilic amino acid derivatives, in particular to a method for the N-alkylation of an unprotected amino acid or the N-terminus of an oligopeptide substrate, comprising reacting said unprotected amino acid or oligopeptide substrate with an alcohol, e.g. a fatty alcohol, in the presence of a homogeneous transition metal catalyst.

New insights into molecular recognition of 1,1-bisphosphonic acids by farnesyl diphosphate synthase

As part of our project pointed at the search of new antiparasitic agents against American trypanosomiasis (Chagas disease) and toxoplasmosis a series of 2-alkylaminoethyl-1-hydroxy-1,1-bisphosphonic acids has been designed, synthesized and biologically evaluated against the etiologic agents of these parasitic diseases, Trypanosoma cruzi and Toxoplasma gondii, respectively, and also towards their target enzymes, T. cruzi and T. gondii farnesyl pyrophosphate synthase (FPPS), respectively. Surprisingly, while most pharmacologically active bisphosphonates have a hydroxyl group at the C-1 position, the additional presence of an amino group at C-3 resulted in decreased activity towards either T. cruzi cells or TcFPPS. Density functional theory calculations justify this unexpected behavior. Although these compounds were devoid of activity against T. cruzi cells and TcFPPS, they were efficient growth inhibitors of tachyzoites of T. gondii. This activity was associated with a potent inhibition of the enzymatic activity of TgFPPS. Compound 28 arises as a main example of this family of compounds exhibiting an ED50 value of 4.7 μM against tachyzoites of T. gondii and an IC50 of 0.051 μM against TgFPPS.

Benzolactam derivatives

A benzolactam derivative represented by the following formula (I): STR1 wherein n represents an integer of from 1 to 3; R 1 represents a straight- or branched-chain alkyl group or an aralkyl group; R 2 represents a straight- or branched-chain alkyl group; R 3 and R 4 independently represent a hydrogen atom or a straight- or branched-chain alkyl group, and when R 3 and R 4 are adjacent each other on the phenyl group, they may be combined to form a cycloalkyl ring together with two carbon atoms of the phenyl group to which R 3 and R 4 bind, and said cycloalkyl ring may optionally have one or more substituents; and a anti-retroviral agent comprising the same as an active ingredient.